Biomarkers and short-term prognosis in COVID-19

References

• Aboughdir, M., et al., 2020. Prognostic value of cardiovascular biomarkers in COVID-19: a review. Viruses, 12 (5), 527.
   Web of Science ®Google Scholar
• Bardaji, A., et al., 2015. Troponina elevada en pacientes sin síndrome coronario agudo. Revista española de cardiología, 68 (6), 469–476.
   PubMed Web of Science ®Google Scholar
• Chen, T., et al., 2020. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ (clinical research ed.), 368, m1091.
   PubMed Web of Science ®Google Scholar
• DeLong, E.R., DeLong, D.M., and Clarke-Pearson, D.L., 1988. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics, 44 (3), 837–845.
   PubMed Web of Science ®Google Scholar
• Deng, X., et al., 2020. Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis. Clinical chemistry and laboratory medicine, 58 (8), 1172–1181.
   PubMed Web of Science ®Google Scholar
• Frencken, J.F., et al., 2019. Myocardial injury in critically ill patients with community-acquired pneumonia a cohort study. Annals of the American thoracic society, 16 (5), 606–612.
   PubMed Web of Science ®Google Scholar
• Guo, T., et al., 2020. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology, 5 (7), 811–818.
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., et al., 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181 (2), 271–280.e8.
   PubMed Web of Science ®Google Scholar
• Huang, C., et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet (London, England), 395 (10223), 497–506.
   PubMed Web of Science ®Google Scholar
• Huang, I., et al., 2020. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Therapeutic advances in respiratory disease, 14, 175346662093717.
   Web of Science ®Google Scholar
• Imazio, M., et al., 2020. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart (British cardiac society), 106 (15), 1127–1131.
   PubMed Web of Science ®Google Scholar
• In, J. and Lee, D.K., 2019. Survival analysis: part II – applied clinical data analysis. Korean journal of anesthesiology, 72 (5), 441–457.
   PubMed Web of Science ®Google Scholar
• Kermali, M., et al., 2020. The role of biomarkers in diagnosis of COVID-19 – a systematic review. Life sciences, 254, 117788.
   PubMed Web of Science ®Google Scholar
• Lala, A., et al., 2020. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. Journal of the American college of cardiology, 76 (5), 533–546.
   PubMed Web of Science ®Google Scholar
• Li, L., et al., 2020. Retrospective study of risk factors for myocardial damage in patients with critical coronavirus disease 2019 in Wuhan. Journal of the American heart association, 9 (15), e016706.
   PubMed Web of Science ®Google Scholar
• Liu, F., et al., 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. Journal of clinical virology, 127, 104370.
   PubMed Web of Science ®Google Scholar
• Martínez-Camblor, P. and Pardo-Fernández, J.C., 2019. The Youden index in the generalized receiver operating characteristic curve context. International journal of biostatistics, 15 (1), 20.
   Web of Science ®Google Scholar
• Mestre-Gómez, B., et al., 2020. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. Journal of thrombosis and thrombolysis.
   PubMed Web of Science ®Google Scholar
• Mo, P., et al., 2020. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clinical infectious diseases.
   PubMed Web of Science ®Google Scholar
• Poggiali, E., et al., 2020. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. Clinica chimica acta, 509, 135–138.
   PubMed Web of Science ®Google Scholar
• Ponti, G., et al., 2020. Biomarkers associated with COVID-19 disease progression. Critical reviews in clinical laboratory science, 57 (6), 388–399.
   Web of Science ®Google Scholar
• Potempa, L.A., et al., 2020. Insights into the use of C-reactive protein as a diagnostic index of disease severity in COVID-19 infections. American journal of tropical medicine and hygiene, 103 (2), 561–563.
   PubMed Web of Science ®Google Scholar
• Sahu, B.R., et al., 2020. C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection. Clinica chimica acta, 509, 91–94.
   PubMed Web of Science ®Google Scholar
• Shang, W., et al., 2020. The value of clinical parameters in predicting the severity of COVID-19. Journal of medical virology, 92 (10), 2188–2192.
   PubMed Web of Science ®Google Scholar
• Shi, S., et al., 2020a. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan. JAMA cardiology, 5 (7), 802–810.
   PubMed Web of Science ®Google Scholar
• Shi, S., et al., 2020b. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. European heart journal, 41 (22), 2070–2079.
   PubMed Web of Science ®Google Scholar
• Shorr, A.F., et al., 2002. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest, 121 (4), 1262–1268.
   PubMed Web of Science ®Google Scholar
• Siddiqi, H.K., et al., 2020. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. The journal of heart and lung transplantation, 39 (5), 405–407.
   PubMed Web of Science ®Google Scholar
• Soraya, G.V. and Ulhaq, Z.S., 2020. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: an updated meta-analysis. Medicina clínica (English edition), 155 (4), 143–151.
   PubMedGoogle Scholar
• Tan, C., et al., 2020. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. Journal of medical virology, 92 (7), 856–862.
   PubMed Web of Science ®Google Scholar
• Wang, G., et al., 2020. C-reactive protein level may predict the risk of COVID-19 aggravation. Open forum infectious diseases, 7 (5), ofaa153.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., et al., 2020. Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes. Investigative radiology, 55 (6), 332–339.
   PubMed Web of Science ®Google Scholar
• Ye, W., et al., 2020. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respiratory research, 21 (1), 169.
   PubMed Web of Science ®Google Scholar
• Yu, B., et al., 2020. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. Journal of thrombosis and thrombolysis, 50 (3), 548–557.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2020. D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19. Journal of thrombosis and haemostasis, 18 (6), 1324–1329.
   PubMed Web of Science ®Google Scholar
• Zhou, F., et al., 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395 (10229), 1054–1062.
   PubMed Web of Science ®Google Scholar